Financhill
Buy
51

BAX Quote, Financials, Valuation and Earnings

Last price:
$34.72
Seasonality move :
2.47%
Day range:
$34.30 - $35.25
52-week range:
$28.34 - $44.01
Dividend yield:
2.64%
P/E ratio:
167.20x
P/S ratio:
1.39x
P/B ratio:
2.56x
Volume:
3.9M
Avg. volume:
5.2M
1-year change:
-15%
Market cap:
$17.8B
Revenue:
$10.6B
EPS (TTM):
-$1.28

Analysts' Opinion

  • Consensus Rating
    Baxter International has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 11 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $39.92, Baxter International has an estimated upside of 14.51% from its current price of $34.86.
  • Price Target Downside
    According to analysts, the lowest downside price target is $30.00 representing 13.94% downside risk from its current price of $34.86.

Fair Value

  • According to the consensus of 15 analysts, Baxter International has 14.51% upside to fair value with a price target of $39.92 per share.

BAX vs. S&P 500

  • Over the past 5 trading days, Baxter International has overperformed the S&P 500 by 1.68% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Baxter International does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Baxter International has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Baxter International reported revenues of $2.8B.

Earnings Growth

  • Baxter International earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Baxter International reported earnings per share of -$1.00.
Enterprise value:
29.3B
EV / Invested capital:
1.45x
Price / LTM sales:
1.39x
EV / EBIT:
124.60x
EV / Revenue:
2.28x
PEG ratio (5yr expected):
--
EV / Free cash flow:
52.34x
Price / Operating cash flow:
31.88x
Enterprise value / EBITDA:
36.03x
Gross Profit (TTM):
$4.8B
Return On Assets:
-2.41%
Net Income Margin (TTM):
-5.05%
Return On Equity:
-8.24%
Return On Invested Capital:
-3.07%
Operating Margin:
-0.04%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $10.2B $12.5B $12.9B $2.7B $2.8B
Gross Profit $3.6B $4.5B $4.8B $1.1B $959M
Operating Income $47M $595M $570M $318M -$1M
EBITDA -$1.7B $1.6B $812M $599M -$176M
Diluted EPS -$4.83 $5.22 -$1.28 $0.48 -$1.00
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $8.4B $8.9B $8B $9.6B $8.9B
Total Assets $20B $33.5B $28.3B $28.3B $25.8B
Current Liabilities $3.3B $4.2B $4.7B $6.5B $6.5B
Total Liabilities $11.3B $24.4B $22.4B $19.8B $18.8B
Total Equity $8.7B $9.1B $5.9B $8.5B $7B
Total Debt $6.2B $17.7B $16.6B $13.8B $13.1B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $1.2B $1.7B $1B $531M $488M
Cash From Investing -$931M $3.2B -$626M -$230M -$205M
Cash From Financing -$1.4B -$3.5B -$1.1B -$2.9B $141M
Free Cash Flow $576M $1.3B $559M $439M $351M
BAX
Sector
Market Cap
$17.8B
$38.4M
Price % of 52-Week High
79.22%
44.83%
Dividend Yield
2.64%
0%
Shareholder Yield
--
-0.67%
1-Year Price Total Return
-15%
-40.84%
Beta (5-Year)
0.603
0.772
Dividend yield:
2.64%
Annualized payout:
$1.04
Payout ratio:
-90.91%
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $34.22
200-day SMA
Buy
Level $34.32
Bollinger Bands (100)
Buy
Level 30.24 - 35.4
Chaikin Money Flow
Buy
Level 951.4M
20-day SMA
Buy
Level $32.33
Relative Strength Index (RSI14)
Buy
Level 64.68
ADX Line
Buy
Level 30.96
Williams %R
Neutral
Level -21.978
50-day SMA
Buy
Level $31.16
MACD (12, 26)
Buy
Level 0.98
25-day Aroon Oscillator
Buy
Level 36
On Balance Volume
Neutral
Level 504.5M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.824)
Sell
CA Score (Annual)
Level (-1.2818)
Buy
Beneish M-Score (Annual)
Level (-2.7337)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-2.0244)
Buy
Piotroski F Score (Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Stock Forecast FAQ

In the current month, BAX has received 3 Buy ratings 11 Hold ratings, and 1 Sell ratings. The BAX average analyst price target in the past 3 months is $39.92.

  • Where Will Baxter International Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Baxter International share price will rise to $39.92 per share over the next 12 months.

  • What Do Analysts Say About Baxter International?

    Analysts are divided on their view about Baxter International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Baxter International is a Sell and believe this share price will drop from its current level to $30.00.

  • What Is Baxter International's Price Target?

    The price target for Baxter International over the next 1-year time period is forecast to be $39.92 according to 15 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 11 analysts rate the stock a Hold.

  • Is BAX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Baxter International is a Hold. 11 of 15 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of BAX?

    You can purchase shares of Baxter International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Baxter International shares.

  • What Is The Baxter International Share Price Today?

    Baxter International was last trading at $34.72 per share. This represents the most recent stock quote for Baxter International. Yesterday, Baxter International closed at $34.86 per share.

  • How To Buy Baxter International Stock Online?

    In order to purchase Baxter International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GEO Stock a Buy, Sell or Hold?
Is GEO Stock a Buy, Sell or Hold?

The GEO Group (NYSE:GEO) is a private prison and mental…

Why Did Sunrise Communications Stock Drop?
Why Did Sunrise Communications Stock Drop?

Sunrise Communications (NASDAQ:SNRE) is a Swiss mobile telephone, TV and…

Will Rocket Lab Stock Recover?
Will Rocket Lab Stock Recover?

Shares of space vehicle launch company Rocket Lab (NASDAQ:RKLB) have…

Stock Ideas

Buy
59
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Sell
46
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
83
THLLY alert for Mar 4

Thales [THLLY] is up 5% over the past day.

Buy
89
BAESY alert for Mar 4

BAE Systems PLC [BAESY] is down 1.75% over the past day.

Sell
33
GDS alert for Mar 4

GDS Holdings [GDS] is up 11.47% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock